We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

M&G Recovery Class I - Income (GBP)

Sell:149.24p Buy:149.24p Change: 0.37p (0.25%)
Prices as at 13 November 2026
Sell:149.24p
Buy:149.24p
Change: 0.37p (0.25%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Invest now
Prices as at 13 November 2026
Sell:149.24p
Buy:149.24p
Change: 0.37p (0.25%)
Prices as at 13 November 2026
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Invest now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Asset Allocation

X-ray asset allocation
Key % Net Assets
UK Equities 86.72%
International Equities 12.19%
Cash and Equiv. 0.72%
International Bonds 0.19%
Alternative Trading Strategies 0.11%
UK Corporate Bonds 0.06%
Other 0.01%

Top 10 holdings

Stock name % Weight Country Sector
1 HSBC HOLDINGS 9.21% GBR Banks
2 SHELL 5.27% GBR Non-Renewable Energy
3 BP P.L.C. 4.93% GBR Non-Renewable Energy
4 MESOBLAST LIMITED 3.72% AUS Pharmaceuticals & Biotechnology
5 LLOYDS BANKING GROUP 3.64% GBR Banks
6 IMPERIAL BRANDS 3.62% GBR Tobacco
7 ASTRAZENECA 3.46% GBR Pharmaceuticals & Biotechnology
8 GSK 3.15% GBR Pharmaceuticals & Biotechnology
9 NATIONAL GRID 3.00% GBR Gas, Water & Multi-utilities
10 OXFORD BIOMEDICA 2.73% GBR Pharmaceuticals & Biotechnology

Fund Analysis is only available on the desktop version of our website. This can be accessed using a desktop or laptop PC or some larger tablets.

You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Invest now